Orphan drugs for rare diseases have helped or saved hundreds of thousands of patients like 2-year-old Luke Whitbeck, but families and insurers are picking up the astronomical cost.
Drugmakers have brought almost 450 orphan drugs to market and collected rich incentives but nearly a third of those products aren’t new or were repurposed multiple times, an investigation shows.
President-elect Donald Trump’s Cabinet pick Tom Price “assisted” a company and campaign donor who tapped executives with an urgent request to donate.
Price and another influential GOP congressman got a discounted deal as an Australian firm seeking federal approval sought “sophisticated U.S. investors.”
Rep. Tom Price advocated on everything from a sperm test to a hot pepper ingredient on behalf of medical interests that included campaign donors.
While hundreds of his former patients submit claims for restitution, a Detroit cancer doctor convicted of making millions by purposefully poisoning them with drugs they didn’t need vows to prove his innocence.